Despite its widespread use, H&E staining has some limitations. It does not provide specific information about the molecular characteristics of cancer cells, which can be crucial for determining the appropriate treatment. Additionally, it may not detect very subtle changes in tissue architecture or small groups of malignant cells. For these reasons, H&E staining is often complemented by immunohistochemistry and molecular diagnostics to provide a more comprehensive analysis.
